|
Critical Care 2011
Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivorsDOI: 10.1186/cc10464 Keywords: interleukin 12, interleukin 6, human leukocyte antigen-DR, peripheral blood mononuclear cells, severe sepsis Abstract: We designed this prospective observational study to measure monocyte human leukocyte antigen (HLA)-DR expression, plasma cytokine levels and cytokine responses on days 1 and 7 in stimulated peripheral blood mononuclear cells (PBMCs) of healthy controls and patients with severe sepsis.Of the 35 enrolled patients, 23 survived for 28 days and 12 died, 6 of whom died within 7 days. Plasma levels of IL-1β, IL-6, IL-10, IL-17, transforming growth factor (TGF)-β1 and TNF-α were higher, but plasma IL-12 level was lower in septic patients than those in controls. Day 1 plasma levels of IL-1β, IL-6, IL-10 and TGF-β1 in nonsurvivors were higher than those in survivors. Day 7 plasma IL-10 levels in nonsurvivors were higher than in survivors. IL-1β response was higher, but IL-12 and TNF-α responses were lower in septic patients than in controls. Day 1 IL-6 response was lower, but day 1 TGF-β1 response was higher in nonsurvivors than in survivors. Plasma IL-6 and IL-10 levels were decreased in survivors after 6 days. IL-6 response was decreased in survivors after 6 days, but IL-12 response was increased. Monocyte percentage was higher, but positive HLA-DR percentage in monocytes and mean fluorescence intensity (MFI) of HLA-DR were lower in septic patients than in controls. MFI of HLA-DR was increased in survivors after 6 days.Monocyte HLA-DR expression and IL-12 response from PBMCs are restored in patients who survive severe sepsis.Sepsis is characterized by an acute release of many inflammatory mediators. The balance between pro- and anti-inflammatory mediators influences the survival rate of septic patients. In severe sepsis, immune system failure and sepsis-induced immunosuppression may result in death [1,2]. Loss of macrophage and monocyte expression of the major histocompatibility complex is one of the mechanisms involved, as is diminished surface expression of human leukocyte antigen-DR (HLA-DR) on monocytes [3]. However, not all studies have shown such results [4,5].A shift
|